These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8681837)

  • 1. [Drugs for impotence].
    Lukkarinen O; Pelkonen R
    Duodecim; 1995; 111(8):771-6. PubMed ID: 8681837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erectile dysfunction].
    Lyngdorf P
    Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endocavernous drug infusions revisited].
    Bellorofonte C; Ruoppolo M; Dell'Acqua S; Zaatar C; Ferri PM; Yamak R; Tagliaferri A; Tombolini P
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):475-9. PubMed ID: 1838835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biweekly intracavernous administration of papaverine for erectile dysfunction.
    Mooradian AD; Morley JE; Kaiser FE; Davis SS; Viosca SP; Korenman SC
    West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection.
    Kadioğlu A; Memişoğlu K; Sazoya O; Tüzün E
    Arch Esp Urol; 1998 Sep; 51(7):739-40. PubMed ID: 9807905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment of impotence.
    Malloy TR; Malkowicz B
    Urol Clin North Am; 1987 May; 14(2):297-305. PubMed ID: 2883750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprostadil for the treatment of erectile dysfunction.
    Kupecz D
    Nurse Pract; 1996 May; 21(5):143-5. PubMed ID: 8734631
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
    Rodriguez Antolin A; Morales JM; Andrés A; Fernández Aparicio T; Díaz González R; Pamplona M; Alvarez E
    Transplant Proc; 1992 Feb; 24(1):105-6. PubMed ID: 1539195
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamics of erection: current pharmacological findings].
    Dorémieux J
    Ann Urol (Paris); 1985; 19(5):327-32. PubMed ID: 2867735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erection induced by papaverine].
    Török A; Székely J; Götz F
    Orv Hetil; 1988 Nov; 129(45):2401-3. PubMed ID: 3186244
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative tolerability and efficacy of treatments for impotence.
    Meinhardt W; Kropman RF; Vermeij P
    Drug Saf; 1999 Feb; 20(2):133-46. PubMed ID: 10082071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yohimbine plus intracavernous vasodilators in mild vasculogenic impotence.
    Quadraccia A; Salvini A; Cordani C; Pizzi P
    Acta Urol Belg; 1988; 56(2):272-8. PubMed ID: 3400531
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of intracavernosal injection of papaverine hydrochloride on orgasm latency.
    Levitt EE; Mulcahy JJ
    J Sex Marital Ther; 1995; 21(1):39-41. PubMed ID: 7608997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
    Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
    Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The post-investigation questionnaire (PIO-R): a practical instrument to assess erectile response after intracavernous injection.
    Vruggink PA; Diemont WL; Meuleman EJ
    Int J Impot Res; 1996 Jun; 8(2):59-62. PubMed ID: 8858391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence.
    Knoll LD; Benson RC; Bilhartz DL; Minich PJ; Furlow WL
    J Urol; 1996 Jan; 155(1):144-6. PubMed ID: 7490815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsurgical management options in impotence.
    Morales A
    Hosp Pract (Off Ed); 1993 Mar; 28(3A):15-6, 19-20, 23-4. PubMed ID: 8450002
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 20. Afrodex in the treatment of male impotence: a double-blind cross-over study.
    Miller WW
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):354-9. PubMed ID: 4969675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.